New Fragmentome Technology Can Detect Early Liver Fibrosis And Cirrhosis

Researchers astatine the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy trial utilizing genome-wide cell-free DNA (cfDNA) fragmentation patterns and repetition landscapes tin observe early liver fibrosis and cirrhosis, and whitethorn besides uncover signals of broader chronic illness burden.

The investigation was supported successful portion by nan National Institutes of Health, and nan findings, published March 4 in Science Translational Medicine, correspond nan first clip this fragmentome technology, initially studied successful cancer, has been applied systematically to discovery of chronic noncancer conditions.

Liquid biopsies based connected cfDNA person shown occurrence successful detecting cancer, but their imaginable successful different diseases has remained mostly unexplored. In nan caller study, investigators utilized whole-genome sequencing to analyse cfDNA fragmentomes from 1,576 group pinch liver illness and different comorbidities, examining DNA from crossed their full genomes. They examined part size and really nan fragments were distributed crossed nan genome, including successful antecedently uncharacterized repetitive regions, to look for signs of disease.

In each analysis, astir 40 cardinal fragments spanning thousands of genomic regions were evaluated - much information than almost immoderate different liquid biopsy test. Machine-learning algorithms were utilized to benignant done these large-scale information to place disease-specific fragmentation signatures. This AI exertion allowed nan squad to zero successful connected nan astir informative patterns and create a classifying strategy that detected early liver disease, precocious fibrosis and cirrhosis pinch precocious sensitivity.

This builds straight connected our earlier fragmentome activity successful cancer, but now utilizing AI and genome-wide fragmentation profiles of cell-free DNA to attraction connected chronic diseases. For galore of these illnesses, early discovery could make a profound difference, and liver fibrosis and cirrhosis are important examples. Liver fibrosis is reversible successful early its stages, but if near undetected, it tin advancement to cirrhosis and yet summation nan consequence of liver cancer."

Victor Velculescu, M.D., Ph.D., co-director of nan crab genetics and epigenetics program, Johns Hopkins Kimmel Cancer Center and co-senior writer of nan study

Unlike different liquid biopsy technologies that look for cancer-related cistron mutations, nan fragmentome analyzes really DNA pieces are cut, packaged and distributed crossed nan genome, which is applicable to diseases beyond cancer, including underlying wellness conditions that tin yet lead to crab development, explains nan team, which was besides co-led by Robert Scharpf, Ph.D., professor of oncology, and Jill Phallen, Ph.D., adjunct professor of oncology.

"The truth that we are not looking for individual mutations is what makes this study truthful powerful," says first writer Akshaya Annapragada, an M.D./Ph.D. student moving successful nan Velculescu lab. "We are analyzing nan full fragmentome, which contains a tremendous magnitude of accusation astir a person's physiologic state. The standard of these data, coupled pinch instrumentality learning, enables improvement of circumstantial classifiers for galore different wellness conditions."

An estimated 100 cardinal group successful nan United States person liver conditions that put them astatine precocious consequence for cirrhosis and cancer, says Velculescu. However, he notes, existing blood-based markers for fibrosis person constricted sensitivity, peculiarly successful early disease. Current humor testing does not observe early fibrosis, and detects cirrhosis only astir half nan time, while disposable imaging devices require specialized ultrasound aliases magnetic resonance equipment, which whitethorn not beryllium accessible to each patients.

"Many individuals astatine consequence don't cognize they person liver disease," Velculescu says. "If we tin intervene earlier - earlier fibrosis progresses to cirrhosis aliases crab - nan effect could beryllium substantial."

In immoderate cases, he says, early discovery of these precursor conditions could person an moreover greater impact, alerting doctors to treatable conditions that, done intervention, could forestall nan improvement of cancer.

The origins of nan study trace backmost to a 2023 Cancer Discovery liver crab fragmentome study by Velculescu and team. When analyzing patients pinch liver cancer, nan squad observed individuals pinch fibrosis aliases cirrhosis whose fragmentation profiles appeared mostly normal but showed subtle signals of disease-related changes. That study prompted a focused investigation into nan fragmentome of liver fibrosis and cirrhosis to uncover nan disease-specific patterns utilized successful nan existent study.

In a cohort of 570 individuals presenting pinch suspected superior illness, nan squad developed a fragmentation comorbidity scale that distinguished individuals pinch precocious versus debased Charlson Comorbidity Index scores, a communal instrumentality utilized by doctors and researchers to estimate really different wellness conditions whitethorn impact a person's consequence for death. The fragmentome scale independently predicted wide endurance and, successful immoderate analyses, proved much circumstantial than accepted inflammatory markers. The researchers besides recovered that immoderate circumstantial fragmentation signatures correlated pinch worse objective outcomes.

"The fragmentome tin service arsenic a instauration for building different classifiers for different diseases, and importantly, these classifiers are disease-specific and do not cross-react," Annapragada says. "A liver fibrosis classifier is chopped from a crab classifier. This is simply a unique, disease-specific trial built from nan aforesaid underlying platform."

Beyond liver disease, nan study examined a organization astatine precocious consequence for different conditions. The researchers besides detected fragmentomic signals associated pinch cardiovascular, inflammatory and neurodegenerative conditions. The researchers constituent retired that nan study did not see capable numbers to create disease-specific classifiers for each of these conditions, but alternatively propose broader applicability, which will beryllium 1 attraction of ongoing research.

The researchers statement that nan liver fibrosis assay described successful nan study is simply a prototype and not yet a objective test. They opportunity adjacent steps see further improvement and validation of nan liver illness classifier arsenic good arsenic exploration of fragmentome signatures successful further chronic conditions.